Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Price:
21.55 CNY
-1.33%
Market Closed
Updated:
May 7, 2024
Income Statement
Earnings Waterfall
Yixintang Pharmaceutical Group Co Ltd
Yixintang Pharmaceutical Group Co Ltd
|
Revenue
|
18.2B
CNY
|
|
Cost of Revenue
|
-12.1B
CNY
|
|
Gross Profit
|
6.1B
CNY
|
|
Operating Expenses
|
-4.7B
CNY
|
|
Operating Income
|
1.4B
CNY
|
|
Other Expenses
|
-356.1m
CNY
|
|
Net Income
|
1B
CNY
|
Income Statement
Yixintang Pharmaceutical Group Co Ltd
Yixintang Pharmaceutical Group Co Ltd
Currency: CNY
| Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||||
| Revenue |
3 995
N/A
|
4 236
+6%
|
4 428
+5%
|
4 589
+4%
|
4 854
+6%
|
5 080
+5%
|
5 321
+5%
|
5 600
+5%
|
5 774
+3%
|
5 971
+3%
|
6 249
+5%
|
6 584
+5%
|
6 949
+6%
|
7 316
+5%
|
7 751
+6%
|
8 116
+5%
|
8 391
+3%
|
8 768
+4%
|
9 176
+5%
|
9 585
+4%
|
9 945
+4%
|
10 219
+3%
|
10 479
+3%
|
10 978
+5%
|
11 448
+4%
|
12 056
+5%
|
12 656
+5%
|
12 998
+3%
|
13 329
+3%
|
13 916
+4%
|
14 587
+5%
|
15 154
+4%
|
15 851
+5%
|
16 115
+2%
|
17 432
+8%
|
17 872
+3%
|
18 142
+2%
|
18 219
+0%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(2 399)
|
(2 548)
|
(2 692)
|
(2 747)
|
(2 920)
|
(3 016)
|
(3 139)
|
(3 265)
|
(3 364)
|
(3 496)
|
(3 730)
|
(3 957)
|
(4 173)
|
(4 389)
|
(4 613)
|
(4 797)
|
(4 941)
|
(5 209)
|
(5 524)
|
(5 838)
|
(6 129)
|
(6 294)
|
(6 468)
|
(6 840)
|
(7 212)
|
(7 663)
|
(8 194)
|
(8 344)
|
(8 407)
|
(8 763)
|
(9 307)
|
(9 721)
|
(10 342)
|
(10 527)
|
(11 486)
|
(11 665)
|
(11 925)
|
(12 146)
|
|
| Gross Profit |
1 597
N/A
|
1 688
+6%
|
1 737
+3%
|
1 842
+6%
|
1 933
+5%
|
2 065
+7%
|
2 183
+6%
|
2 335
+7%
|
2 410
+3%
|
2 475
+3%
|
2 519
+2%
|
2 627
+4%
|
2 776
+6%
|
2 927
+5%
|
3 138
+7%
|
3 319
+6%
|
3 450
+4%
|
3 559
+3%
|
3 652
+3%
|
3 748
+3%
|
3 816
+2%
|
3 924
+3%
|
4 011
+2%
|
4 139
+3%
|
4 236
+2%
|
4 394
+4%
|
4 463
+2%
|
4 654
+4%
|
4 922
+6%
|
5 153
+5%
|
5 281
+2%
|
5 433
+3%
|
5 509
+1%
|
5 588
+1%
|
5 946
+6%
|
6 207
+4%
|
6 217
+0%
|
6 073
-2%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(1 277)
|
(1 362)
|
(1 393)
|
(1 486)
|
(1 576)
|
(1 686)
|
(1 804)
|
(1 928)
|
(1 984)
|
(2 043)
|
(2 101)
|
(2 202)
|
(2 322)
|
(2 450)
|
(2 581)
|
(2 713)
|
(2 781)
|
(2 843)
|
(2 939)
|
(2 999)
|
(3 073)
|
(3 171)
|
(3 257)
|
(3 379)
|
(3 419)
|
(3 524)
|
(3 565)
|
(3 708)
|
(3 914)
|
(4 088)
|
(4 100)
|
(4 338)
|
(4 450)
|
(4 503)
|
(4 585)
|
(4 764)
|
(4 758)
|
(4 699)
|
|
| Selling, General & Administrative |
(1 246)
|
(1 311)
|
(1 353)
|
(1 420)
|
(1 508)
|
(1 627)
|
(1 749)
|
(1 905)
|
(1 962)
|
(2 015)
|
(2 031)
|
(2 126)
|
(2 239)
|
(2 370)
|
(2 505)
|
(2 627)
|
(2 691)
|
(2 755)
|
(2 862)
|
(2 931)
|
(3 041)
|
(3 159)
|
(3 244)
|
(3 376)
|
(3 396)
|
(3 483)
|
(3 515)
|
(3 639)
|
(3 838)
|
(4 015)
|
(4 054)
|
(4 281)
|
(4 379)
|
(4 390)
|
(4 543)
|
(4 622)
|
(4 625)
|
(4 598)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(3)
|
(4)
|
(4)
|
(5)
|
(4)
|
(3)
|
(5)
|
(9)
|
(9)
|
(12)
|
(13)
|
|
| Depreciation & Amortization |
0
|
0
|
(36)
|
0
|
0
|
0
|
(51)
|
0
|
0
|
0
|
(66)
|
0
|
0
|
0
|
(69)
|
0
|
0
|
0
|
(70)
|
0
|
0
|
0
|
(72)
|
0
|
0
|
0
|
(78)
|
0
|
0
|
0
|
(90)
|
0
|
0
|
0
|
(90)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(31)
|
(51)
|
(4)
|
(66)
|
(68)
|
(59)
|
(5)
|
(23)
|
(22)
|
(28)
|
(5)
|
(75)
|
(83)
|
(80)
|
(6)
|
(87)
|
(90)
|
(87)
|
(6)
|
(67)
|
(32)
|
(12)
|
59
|
(3)
|
(23)
|
(40)
|
28
|
(67)
|
(72)
|
(68)
|
50
|
(52)
|
(68)
|
(108)
|
56
|
(133)
|
(121)
|
(88)
|
|
| Operating Income |
320
N/A
|
326
+2%
|
343
+5%
|
356
+4%
|
357
+0%
|
379
+6%
|
378
0%
|
407
+8%
|
425
+5%
|
432
+1%
|
418
-3%
|
426
+2%
|
455
+7%
|
477
+5%
|
557
+17%
|
606
+9%
|
669
+11%
|
716
+7%
|
713
0%
|
749
+5%
|
743
-1%
|
753
+1%
|
754
+0%
|
760
+1%
|
817
+8%
|
870
+6%
|
897
+3%
|
947
+6%
|
1 008
+7%
|
1 066
+6%
|
1 181
+11%
|
1 095
-7%
|
1 059
-3%
|
1 085
+2%
|
1 361
+25%
|
1 442
+6%
|
1 460
+1%
|
1 375
-6%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(10)
|
(7)
|
1
|
3
|
4
|
(3)
|
(7)
|
(15)
|
(22)
|
(21)
|
(25)
|
(36)
|
(39)
|
(48)
|
(47)
|
(46)
|
(40)
|
(29)
|
(11)
|
(13)
|
(10)
|
(3)
|
8
|
10
|
18
|
26
|
34
|
13
|
(6)
|
(35)
|
(89)
|
(104)
|
(113)
|
(116)
|
(92)
|
(92)
|
(76)
|
(76)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(5)
|
(4)
|
(4)
|
(18)
|
1
|
1
|
0
|
(26)
|
1
|
1
|
2
|
(16)
|
(2)
|
(1)
|
0
|
(27)
|
(5)
|
(12)
|
(12)
|
(40)
|
(31)
|
(25)
|
(16)
|
|
| Gain/Loss on Disposition of Assets |
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
1
|
(1)
|
2
|
2
|
3
|
5
|
13
|
14
|
14
|
16
|
18
|
20
|
20
|
24
|
39
|
39
|
38
|
32
|
7
|
9
|
8
|
10
|
13
|
12
|
23
|
28
|
41
|
43
|
33
|
29
|
31
|
28
|
35
|
41
|
6
|
(15)
|
(24)
|
(36)
|
|
| Pre-Tax Income |
311
N/A
|
317
+2%
|
345
+9%
|
361
+5%
|
363
+1%
|
380
+5%
|
390
+3%
|
404
+4%
|
416
+3%
|
425
+2%
|
409
-4%
|
407
-1%
|
433
+6%
|
449
+4%
|
547
+22%
|
594
+9%
|
664
+12%
|
716
+8%
|
692
-3%
|
746
+8%
|
741
-1%
|
760
+3%
|
749
-1%
|
783
+5%
|
859
+10%
|
925
+8%
|
957
+3%
|
1 001
+5%
|
1 034
+3%
|
1 060
+2%
|
1 097
+3%
|
1 014
-7%
|
970
-4%
|
998
+3%
|
1 235
+24%
|
1 304
+6%
|
1 334
+2%
|
1 247
-7%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(35)
|
(28)
|
(50)
|
(53)
|
(50)
|
(57)
|
(44)
|
(42)
|
(47)
|
(46)
|
(56)
|
(62)
|
(59)
|
(64)
|
(124)
|
(138)
|
(165)
|
(191)
|
(172)
|
(182)
|
(177)
|
(175)
|
(146)
|
(151)
|
(177)
|
(202)
|
(168)
|
(156)
|
(138)
|
(112)
|
(179)
|
(182)
|
(160)
|
(168)
|
(222)
|
(223)
|
(229)
|
(217)
|
|
| Income from Continuing Operations |
276
|
289
|
295
|
308
|
313
|
323
|
346
|
361
|
368
|
379
|
354
|
345
|
374
|
385
|
423
|
457
|
499
|
525
|
520
|
564
|
565
|
586
|
603
|
632
|
683
|
724
|
789
|
845
|
895
|
947
|
917
|
832
|
810
|
830
|
1 013
|
1 081
|
1 106
|
1 030
|
|
| Income to Minority Interest |
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
2
|
2
|
2
|
4
|
8
|
6
|
5
|
(3)
|
(11)
|
(9)
|
(11)
|
|
| Net Income (Common) |
279
N/A
|
292
+5%
|
297
+2%
|
310
+4%
|
314
+1%
|
323
+3%
|
346
+7%
|
361
+4%
|
369
+2%
|
379
+3%
|
353
-7%
|
345
-2%
|
373
+8%
|
386
+3%
|
423
+10%
|
457
+8%
|
499
+9%
|
525
+5%
|
521
-1%
|
565
+8%
|
566
+0%
|
587
+4%
|
604
+3%
|
633
+5%
|
683
+8%
|
724
+6%
|
790
+9%
|
846
+7%
|
897
+6%
|
950
+6%
|
922
-3%
|
840
-9%
|
816
-3%
|
835
+2%
|
1 010
+21%
|
1 070
+6%
|
1 096
+2%
|
1 019
-7%
|
|
| EPS (Diluted) |
0.71
N/A
|
0.56
-21%
|
0.66
+18%
|
0.59
-11%
|
0.6
+2%
|
0.62
+3%
|
0.67
+8%
|
0.69
+3%
|
0.7
+1%
|
0.72
+3%
|
0.68
-6%
|
0.66
-3%
|
0.72
+9%
|
0.74
+3%
|
0.81
+9%
|
0.8
-1%
|
0.87
+9%
|
0.94
+8%
|
0.92
-2%
|
0.99
+8%
|
1
+1%
|
1.04
+4%
|
1.06
+2%
|
1.12
+6%
|
1.2
+7%
|
1.27
+6%
|
1.34
+6%
|
1.42
+6%
|
1.52
+7%
|
1.6
+5%
|
1.56
-3%
|
1.42
-9%
|
1.38
-3%
|
1.41
+2%
|
1.7
+21%
|
1.8
+6%
|
1.84
+2%
|
1.71
-7%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
